ADHD Prevalence in the UK: How Common Is It Really?

ADHD prevalence is one of the most misquoted figures in psychiatry, partly because the answer depends on age, on the criteria applied, and on how the question is asked. This article gives the actual numbers from the best available studies, both global and UK-specific, and explains why diagnosis rates have risen sharply over the past decade.

The short answer

• In children worldwide: pooled prevalence around 5 to 7 percent ^{[1, 3]}.
• In adults worldwide: pooled prevalence around 2.5 to 5 percent depending on methodology ^{[2, 3]}.
• In UK children: most recent estimates fall within the global range; NICE NG87 cites approximately 5 percent ^[5].
• In UK adults: estimates around 3 to 4 percent are commonly cited and align with the adult prevalence data ^{[2, 5]}.

The true rate has been broadly stable for decades. What has risen is the rate at which it is recognised and diagnosed.

Where the global figures come from

The most cited child prevalence estimate is from the Polanczyk meta-analysis, which pooled data across more than three decades and found no genuine increase in true prevalence once methodology was controlled for ^[1]. The headline figure of around 5 to 7 percent has held up across subsequent reviews ^[3].

For adult ADHD, the global meta-analysis by Song and colleagues estimated persistent adult ADHD (those who had ADHD as a child and continue to meet criteria) at around 2.6 percent, and symptomatic adult ADHD (those who currently meet criteria, regardless of childhood diagnosis) at around 6.8 percent worldwide ^[2]. The discrepancy between the two figures matters: it tells us that a large group of adults currently meet criteria without ever having been formally diagnosed in childhood. That is consistent with what is being seen clinically across the UK now.

UK-specific numbers

UK epidemiology supports the international picture:

• The Adult Psychiatric Morbidity Survey 2014 reported a current ADHD symptom prevalence of approximately 9.7 percent screen positive in adults, with around 1.5 percent meeting full diagnostic criteria on structured follow-up ^[4]. The discrepancy between screen-positive and confirmed rates is itself important context: many adults with significant traits do not meet the full clinical threshold.
• NICE NG87 cites approximately 5 percent in UK children and approximately 3 to 4 percent in UK adults as working figures for service planning ^[5].
• A UK primary care cohort study by McKechnie and colleagues found that recorded ADHD diagnoses in UK general practice rose substantially between 2000 and 2018, particularly in adults ^[6]. This is a rise in recognition, not in underlying prevalence.

Why diagnosis rates are rising even though prevalence is stable

Three things have changed over the past fifteen to twenty years:

• Public awareness. ADHD is more discussed, more represented in the media, and easier to recognise in oneself or one's child than it was in the 1990s.
• Diagnostic criteria. The DSM-5 in 2013 explicitly recognised that ADHD persists into adulthood and broadened the adult symptom threshold compared with DSM-IV. Adults who would not have met the old criteria meet the new ones.
• Service availability. More clinicians are trained to assess adult ADHD. Pathways such as Right to Choose in England, and the growth of private providers including NeuroFX, mean that adults who recognise themselves can actually access an assessment, where ten years ago they often could not.

The current wave is not an epidemic. It is a generation of people, particularly women, who were missed in childhood and now have the language and the access to ask the question.

What the numbers do not capture

Population prevalence is not the same as visibility. Several groups are still meaningfully under-diagnosed in UK data:

• Women and girls with the inattentive presentation. Female-to-male diagnosis ratios in children are nearer one to four in research samples but closer to one to ten in routine clinical practice, suggesting under-recognition rather than lower true prevalence ^[3].
• Older adults. Few people in their fifties, sixties and beyond were ever offered an assessment.
• People from minoritised ethnic groups, who are diagnosed at lower rates in UK primary care than the population baseline would predict ^[6].

Population estimates also do not capture severity. Two adults who both meet criteria can have meaningfully different levels of impairment.

What this means for waiting lists and access

The mismatch between the number of adults who currently meet criteria and the capacity of NHS services to assess them is the single biggest reason for the long waiting times across most of the UK. In some regions, waits for an adult ADHD assessment exceed three years.

This is the practical reason the alternatives exist:

• The NHS via GP referral, which is the default but slow.
• How Right to Choose actually works: the legal entitlement in England to request referral to any NHS-contracted provider, often with shorter waits.
• A private assessment with a CQC-registered provider; what private assessment actually looks like covers timeline, cost and outcomes in detail.

What this means in practice

• If the picture fits, you are not unusual. ADHD is approximately as common in adults as moderate or severe depression.
• The fact that diagnosis rates are rising does not mean ADHD is being over-diagnosed. The evidence points to better recognition of a previously missed condition.
• Population numbers do not tell you whether you personally meet criteria. That is a clinical question, answered by a proper assessment.

When to speak to a professional

If the pattern fits across more than one area of life and dates back to childhood, it is worth a clinical conversation. Start with your GP for an NHS referral, or for Right to Choose in England. A private adult ADHD assessment at our Bedford clinic is an alternative where waiting is a barrier. Seek same-day support via 111 (or 999 in an emergency) for any mental health crisis.

Sources

1. Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. International Journal of Epidemiology. 2014;43(2):434-442.
2. Song P, Zha M, Yang Q, Zhang Y, Li X, Rudan I. The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. Journal of Global Health. 2021;11:04009.
3. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews. 2021;128:789-818.
4. McManus S, Bebbington PE, Jenkins R, Brugha T (eds.). Mental health and wellbeing in England: Adult Psychiatric Morbidity Survey 2014. NHS Digital. 2016.
5. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng87
6. McKechnie DGJ, O'Nions E, Bailey J, Hobbs L, Gillespie F, Petersen I. Attention-deficit hyperactivity disorder diagnoses and prescriptions in UK primary care, 2000-2018: population-based cohort study. BJPsych Open. 2023;9(4):e121.